pretickt

Quest Diagnostics Incorporated (DGX)

Healthcare · end-of-day data as of Oct 16, 2026

Quest Diagnostics Incorporated
DGX · $25.94B
$235.00+3.5%last 60 sessions · close Oct 16, 2026
$170.62$246.5352 weeks
Buy · 18 analystsPT $233.86 -0.5%
  • P/E vs own+15.6%
  • P/E vs sector-11.4%
  • Target upside-0.5%
  • Off 52w high-4.7%
  • Insiders-$8.32M
  • FCF yield+4.7%
  • Earnings in6d
  • Trendsideways
  • Sector▲ +16.0%
  • RSI51
  • MA20×50Death 10d ago
  • Volume0.7x
  • Support-1.5%
  • Resistance+4.4%

The average 12-month analyst price target for DGX is $233.86, 0.5% below the last close of $235.00 on Oct 16, 2026; targets range from $194.62 to $258.90. Rating consensus: Buy.

Snapshot

  • P/E24.9x
  • P/E vs sector-11.4%
  • P/E vs own+15.6%
  • Target upside-0.5%
  • ConsensusBuy
  • Market cap$25.94B
  • FCF yield+4.7%
  • Insiders-$8.32M
  • Earnings in6d
  • News1.00

Why it moved

Quest Diagnostics Incorporated (DGX) fell 1.7% on Oct 16, 2026.

The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.

Market (SPY)-1.1%
Healthcare sector+0.4%
DGX specific-1.0%

1 story on the day (30-day average 0.7).

Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.

Price and events

⇔⇕$176$198$220$242Oct 25Jan 26Apr 26Jul 26Oct 26EDEDEDEDE

Last close $235.00 · +27.9% over 1y · E earnings · D dividend · S split · A analyst rating change

Technicals

  • Trendsideways
  • Sector▲ +16.0%
  • MAs20▲ 50▼ 100▲ 200▲
  • Above MAs3 of 4 above
  • MA20×50Death 10d ago
  • RSI51
  • Support-1.5%
  • Resistance+4.4%
  • Off 52w high-4.7%
  • Off ATH-4.7%
  • 52w range$235.00
  • Bollingerupper half
  • MACD0.54
  • ATR+2.2%
  • Volume0.7x

Analyst price targets

Low$194.62
Average$233.86
Median$244.01
High$258.90
Upside-0.5%

11 firms with a target in the last 12 months · last close $235.00 · as of Oct 16, 2026

⇔⇕$166$190$215$239$263Oct 25Mar 26Aug 26Jan 27Jun 27-15%-7%-7%+4%+8%
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets

Strong buy 2 · Buy 7 · Hold 8 · Sell 0 · Strong sell 1

Revenue and free cash flow

Q2 FY2026: Revenue +10.2% year over year, free cash flow 10.8% of revenue, operating margin 15.1%.

RevenueFree cash flow
Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026
Q2 FY2026Jun 30, 2026$3.04B2.84$330M33.7%15.1%10.5%
Q1 FY2026Mar 31, 2026$2.9B2.24$164M32.5%13.8%8.7%
Q4 FY2025Dec 31, 2025$2.81B2.18$307M32.6%13.9%8.7%
Q3 FY2025Sep 30, 2025$2.82B2.16$419M33.7%13.7%8.7%
Q2 FY2025Jun 30, 2025$2.76B2.47$436M34.2%15.9%10.2%
Q1 FY2025Mar 31, 2025$2.65B1.94$197M32.5%13.0%8.3%
Q4 FY2024Dec 31, 2024$2.62B1.95$341M32.7%13.8%8.5%
Q3 FY2024Sep 30, 2024$2.49B1.99$250M32.6%13.3%9.1%

Peers

20D
1IDXXIDEXX Laboratories, Inc.$560.36+2.4%-26.9%+34.9%39.7$44.15B
2IQVIQVIA Holdings Inc.$266.90-1.5%-3.0%+3.6%33.1$43.93B
3WATWaters Corporation$436.95-1.6%-1.6%+4.4%109.0$42.9B
4ILMNIllumina, Inc.$262.54-2.0%-10.6%-16.6%49.0$39.64B
5MTDMettler-Toledo International Inc.$1,622.29-1.0%-1.0%-7.3%36.5$32.51B
6DGXQuest Diagnostics Incorporated$235.00-1.7%-4.7%-0.5%24.9$25.94B
7LHLabcorp Holdings Inc.$317.95-2.2%-6.1%+5.8%26.3$25.79B
8RVTYRevvity, Inc.$152.64-1.3%-3.0%-18.2%72.7$17.03B

Data as of Oct 16, 2026 close.

Latest news

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.